Showcasing excellence in the global vaccine industry

 

The 18th Annual ViE Awards 2025 will once again be a part of the World Vaccine Congress Washington event, to celebrate the industry’s most outstanding achievements. With 13 categories, these awards have been created to honour and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry. 

 

Awards Categories for 2025

 

Best Clinical Trial Company Award
Best Clinical Trial Network Award
Best Central/ Specialty Laboratory Award
Best Contract Research Organization Award
Best Contract Manufacturing Organization Award
Best Production/ Process Development Award
Best New Vaccine Technology/ Platform Award
Best Academic/ Research Team Award
Best Pharma Award
Best Logistics Technology & Cold Chain Delivery Award
Best Prophylactic Vaccine Award
Best Therapeutic Vaccine Award
Best New COVID Vaccine Award

ViE Awards schedule

 

Nominations open: December, 2024 (date to be announced)

Nominations close: January 17, 2025

Voting period: January 31 – February 23, 2025

Shortlist announced: March 14, 2025

 

Winners announced at the ViE awards ceremony on the April 22, 2024

 

BOOK YOUR SEAT

VIEW CATEGORIES

 

 

WOrlD VACCINE CONGRESS WASHINGTON


The ViE Awards runs in conjunction with the World Vaccine Congress Washington.  


The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe since 2000. Following a record attendance in 2024 of 4000 attendees, the World Vaccine Congress Washington will be back in  April 2025 bringing together the most senior and informed industry experts across the entire vaccine landscape.

 

Know More
Book your tickets

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.